Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno–venous extracorporeal membrane oxygenation for viral pneumonia
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2025.08.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Deepa J Arachchillage und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, UK; Department of Haematology, Imperial College H…. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Thrombosis, Blood Coagulation, Hemorrhage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rosetrees, Medical Research Council, NIHR Imperial Biomedical Research Centre.
Abstract (Originalsprache)
BACKGROUND: Bleeding and thrombosis remain leading causes of morbidity and mortality in patients supported by extracorporeal membrane oxygenation (ECMO). OBJECTIVES: To assess hemostatic changes during veno-venous (VV)-ECMO support after respiratory failure due to viral pneumonia and their association with major bleeding, thrombosis, and mortality. METHODS: Coagulation factors (factors [F]II, FV, FVII, FVIII, FIX, FX, FXI, FXII), von Willebrand profile, and thrombin generation (TG) were measured at cannulation, during VV-ECMO (every fifth day), 1 hour, and 24 hours after decannulation in 50 patients (August 2018-January 2020). RESULTS: Median age was 47 (18-68) years, 56% were men, and median VV-ECMO duration was 9 (3-41) days. Intracranial hemorrhage and ischemic stroke were detected in 10% and 4%, respectively, within 24 hours of initiating VV-ECMO. The 180-day mortality was 10%; 58% developed thrombosis and 28% major bleeding (43% were intracranial hemorrhage). Coagulation factor levels fell significantly within 24 hours of initiating VV-ECMO but returned to normal by day 5. TG decreased significantly throughout VV-ECMO, with nadir at decannulation. Tissue factor pathway inhibitor alpha level increased throughout VV-ECMO and correlated with reduced (r = -0.54, P < .001) and delayed (r = 0.6, P < .001) TG. The von Willebrand factor (VWF) Ristocetin cofactor activity (VWF:RCo)/VWF antigen (VWF:Ag) ratio was significantly reduced by 24 hours of initiation and during VV-ECMO compared to precannulation. In multivariate analyses, older age, thrombocytopenia, increased creatinine level, and reduced TG at cannulation were associated with mortality. VWF:RCo/VWF:Ag ratio
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, UK; Department of Haematology, Imperial College Healthcare National Health Service Trust, London, UK; Department of Hae…
- Department of Haematology, Royal Brompton Hospital, London, UK.
- Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, UK.
- Department of Intensive Care, Harefield Hospital, London, UK.
- North West London Pathology, Imperial College Healthcare Nationa Health Service Trust, London, UK.
- Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, UK; Department of Haematology, Imperial College Healthcare National Health Service Trust, London, UK.
Förderung
- Rosetrees
- Medical Research Council
- NIHR Imperial Biomedical Research Centre
- National Institute for Health and Care Research
- Imperial Health Charity
- British Heart Foundation
Zitieren
APA
Arachchillage, D. J., Gaspar, M., Gierula, M., Kamani, F., Rosenberg, A., Mobayen, G., Karawitage, N., Vinayagam, S., Laffan, M., Ledot, S., & Ahnström, J. (2025). Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno–venous extracorporeal membrane oxygenation for viral pneumonia. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.08.010
Vancouver
Arachchillage DJ, Gaspar M, Gierula M, Kamani F, Rosenberg A, Mobayen G, et al. Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno–venous extracorporeal membrane oxygenation for viral pneumonia. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.08.010
BibTeX
@article{Arachchillage2025,
author = {Arachchillage, Deepa J and Gaspar, Mihaela and Gierula, Magdalena and Kamani, Farah and Rosenberg, Alex and Mobayen, Golzar and Karawitage, Nilanthi and Vinayagam, Saravanan and Laffan, Mike and Ledot, Stephane and Ahnström, Josefin},
title = {Association of coagulation dysfunction with thrombosis, bleeding, and mortality in patients supported by veno–venous extracorporeal membrane oxygenation for viral pneumonia},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2025.08.010}
}
EUVIMED